Oral Sildenafil in Infants With Persistent Pulmonary Hypertension of the Newborn: A Pilot Randomized Blinded Study

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Pediatrics

• Publication date

  2006-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1542/peds.2005-0523PMID 16585301
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment of rebound and chronic pulmonary hypertension with oral sildenafil in an infant with congenital diaphragmatic hernia

  2004cited by this paper
• Clinical and haemodynamic effects of sildenafil in pulmonary hypertension: acute and mid-term effects.

  2004cited by this paper
• Use of sildenafil with inhaled nitric oxide in the management of severe pulmonary hypertension.

  2004cited by this paper
• Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study.

  2004cited by this paper
• Treatment of Primary Pulmonary Hypertension with Oral Sildenafil

  2004cited by this paper
• Interaction between Inhaled Nitric Oxide and Intravenous Sildenafil in a Porcine Model of Meconium Aspiration Syndrome

  2004cited by this paper
• Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension.

  2004cited by this paper
• [Oral sildenafil: a promising drug for persistent neonatal pulmonary hypertension].

  2004cited by this paper
• Effects of phosphodiesterase inhibition on cortical spreading depression and associated changes in extracellular cyclic GMP.

  2004cited by this paper
• Heparin therapy in giant cell arteritis

  2004cited by this paper
• Postnatal Maturation of Phosphodiesterase 5 (PDE5) in Piglet Pulmonary Arteries: Activity, Expression, Effects of PDE5 Inhibitors, and Role of the Nitric Oxide/Cyclic GMP Pathway

  2004cited by this paper
• Cost-effectiveness of inhaled nitric oxide for the management of persistent pulmonary hypertension of the newborn.

  2004cited by this paper
• Sildenafil, a Phosphodiesterase-5 Inhibitor, Delays Gastric Emptying and Gastrointestinal Transit of Liquid in Awake Rats

  2003cited by this paper
• Augmentation of the NO-cGMP cascade induces anxiogenic-like effect in mice.

  2003cited by this paper
• [Sildenafil in the treatment of pulmonary hypertension].

  2003cited by this paper
• Acute electroretinographic changes during Sildenafil (Viagra) treatment for erectile dysfunction*

  2003cited by this paper
• Sildenafil as a treatment for pulmonary hypertension

  2003cited by this paper
• Phosphodiesterase inhibitors for persistent pulmonary hypertension of the newborn: A review

  2003cited by this paper
• Effect of sildenafil on the acute pulmonary vasodilator response to inhaled nitric oxide in adults with primary pulmonary hypertension.

  2002cited by this paper
• Neurologic, Psychological, and Aggressive Disturbances with Sildenafil

  2002cited by this paper
• Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide.

  2002cited by this paper
• Oral Sildenafil Is an Effective and Specific Pulmonary Vasodilator in Patients With Pulmonary Arterial Hypertension: Comparison With Inhaled Nitric Oxide

  2002cited by this paper
• Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial.

  2002cited by this paper
• Intravenous sildenafil lowers pulmonary vascular resistance in a model of neonatal pulmonary hypertension.

  2002cited by this paper
• Persistent pulmonary hypertension of the newborn. Rational therapy based on pathophysiology.

  2001cited by this paper
• Sildenafil-mediated reduction in retinal function in heterozygous mice lacking the gamma-subunit of phosphodiesterase.

  2001cited by this paper
• Clinical approach to inhaled nitric oxide therapy in the newborn with hypoxemia.

  2000cited by this paper
• Inhibition of cyclic GMP-binding cyclic GMP-specific phosphodiesterase (Type 5) by sildenafil and related compounds.

  1999cited by this paper
• Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group.

  1998cited by this paper
• Persistent pulmonary hypertension of the newborn.

  1995cited by this paper
• Persistent Pulmonary Hypertension of the Newborn

  1991cited by this paper

• The Use of Treprostinil for Bronchopulmonary Dysplasia Associated Pulmonary Hypertension

  2026cites this paper
• Testing Higher Doses of Sildenafil to Repair Brain Injury Secondary to Birth Asphyxia: An Open-Label Dose-Finding Phase 1b Clinical Trial (SANE-02).

  2025cites this paper
• Global, regional and national trends in the burden of persistent pulmonary hypertension of the newborn and essentials of its management from 1993 to 2023: a scoping review

  2025cites this paper
• Electrical cardiometry changes in full-term neonates with persistent pulmonary hypertension on high-frequency mechanical ventilation versus conventional mechanical ventilation

  2025influential citation
• Pulmonary vasodilator use in very preterm infants in United States children’s hospitals

  2025cites this paper
• Quality by design (QbD)-driven formulation of sildenafil citrate microparticles using quasi-emulsion technique for pulmonary delivery: an in vitro study

  2025cites this paper
• Efficacy of milrinone plus sildenafil in the treatment of neonates with persistent pulmonary hypertension: A single center, randomized controlled trial from a resource limited setting.

  2025cites this paper
• Vasodilators for persistent pulmonary hypertension of the newborn: A network meta‐analysis

  2024cites this paper
• Perioperative sildenafil therapy in pulmonary hypertension associated with congenital cardiac disease: An updated meta-analysis.

  2024cites this paper
• Milrinone in persistent pulmonary hypertension of newborn: a scoping review

  2024cites this paper
• Study on the comparison between Bosentan and Macitentan in the treatment of persistent pulmonary hypertension of the newborns, simultaneously on sildenafil: A randomized double-blinded non-inferiority parallel clinical trial.

  2024cites this paper
• Pulmonary vasodilator use in very preterm infants in United States children’s hospitals

  2024cites this paper
• Persistent pulmonary hypertension of the newborn

  2024cites this paper
• Comparison of Different Treatments of Persistent Pulmonary Hypertension of the Newborn: A Systematic Review and Network Meta-Analysis*

  2024cites this paper
• Echocardiographic markers at diagnosis of persistent pulmonary hypertension of the newborn

  2024cites this paper
• Sildenafil in Pulmonary Hypertension Associated with Bronchopulmonary Dysplasia: Friend or Foe?

  2023cites this paper
• Intravenous sildenafil for the treatment of persistent pulmonary hypertension of the newborn in a resource-limited setting

  2023cites this paper
• Intra-amniotic sildenafil administration in rabbits: Safety, pharmacokinetics, organ distribution and histologic evaluation.

  2023cites this paper
• Intra-amniotic sildenafil treatment improves lung blood flow and pulmonary hypertension in congenital diaphragmatic hernia rats

  2023cites this paper
• Neonatal Pulmonary Hypertension: Phenotypes, Physiology, and Management.

  2023cites this paper
• Comparison of tadalafil and sildenafil in controlling neonatal persistent pulmonary hypertension

  2023cites this paper
• Meconium aspiration syndrome: a comprehensive review

  2023cites this paper
• Feasibility and safety of sildenafil to repair brain injury secondary to birth asphyxia (SANE-01): A randomized, double-blind, placebo-controlled phase Ib clinical trial.

  2023cites this paper
• Randomized Controlled Trials of Pulmonary Vasodilator Therapy Adjunctive to Inhaled Nitric Oxide for Persistent Pulmonary Hypertension of the Newborn: A Systematic Review.

  2023cites this paper
• Pulmonary Vasodilator Therapy in Persistent Pulmonary Hypertension of the Newborn.

  2022cites this paper
• Milrinone Versus Sildenafil in Treatment of Neonatal Persistent Pulmonary Hypertension: A Randomized Control Trial

  2022cites this paper
• The Role of Sildenafil in Treating Brain Injuries in Adults and Neonates

  2022cites this paper
• New Therapeutic Targets in Neonatal Pulmonary Hypertension

  2022cites this paper
• Pulmonary vasodilator strategies in neonates with acute hypoxemic respiratory failure and pulmonary hypertension.

  2022cites this paper
• Oral versus intravenous sildenafil for pulmonary hypertension in neonates: a randomized trial

  2022cites this paper
• The use of bosentan and sildenafil as rescue therapy in persistent pulmonary hypertension of the newborn: A single center's experience

  2022cites this paper
• Efficacy of sildenafil in persistent pulmonary hypertension of the newborn.

  2022cites this paper
• Persistent pulmonary hypertension of newborn.

  2022cites this paper
• If We Cannot Use Nitric Oxide for Newborn Persistent Pulmonary Hypertension, is Oral Sildenafil Therapeutic? A Single-center Experience

  2022cites this paper
• Pediatric Pulmonary Hypertension: Definitions, Mechanisms, Diagnosis, and Treatment.

  2021cites this paper
• Title: Clinical Profile of Persistent Pulmonary Hypertension in Neonates with Role of Sildenafil in its Outcome: Rural India NICU Experience

  2021cites this paper
• Persistent Pulmonary Hypertension: A Look Into the Future Therapy

  2021cites this paper
• B-natriuretic peptide serum levels in neonates with persistent pulmonary hypertension

  2021cites this paper
• Evidence-Based Guidelines for Acute Stabilization and Management of Neonates with Persistent Pulmonary Hypertension of the Newborn

  2021cites this paper
• The Efficacy and Safety of Pulmonary Vasodilators in Pediatric Pulmonary Hypertension (PH): A Systematic Review and Meta-analysis

  2021cites this paper
• Update on the use of sildenafil in neonatal pulmonary hypertension: a narrative review of the history, current administration, and future directions

  2021cites this paper
• The Use of Supplemental Hydrocortisone in the Management of Persistent Pulmonary Hypertension of the Newborn

  2021cites this paper
• Effect of pulsatile stretch on unfolded protein response in a new model of the pulmonary hypertensive vascular wall

  2021cites this paper
• Clinical Efficacy and Safety of Different Doses of Sildenafil in the Treatment of Persistent Pulmonary Hypertension of the Newborn: A Network Meta-analysis

  2021cites this paper
• Critical Care Management of the Neonate

  2021cites this paper
• Pathophysiology and Management of Persistent Pulmonary Hypertension of the Newborn.

  2021cites this paper
• Pulmonary hypertension in the child with bronchopulmonary dysplasia

  2021cites this paper
• Comparison of the Efficacy of Milrinone Injection versus Milrinone Plus Oral Sildenafil in Newborns with Pulmonary Arterial Hypertension

  2021cites this paper
• Efficacy and Safety of IV Sildenafil in the Treatment of Newborn Infants With, or at Risk of Persistent Pulmonary Hypertension of the Newborn (PPHN): A Multicenter, Randomized, Placebo-Controlled Trial.

  2021cites this paper
• Inadequate Dosage May Lead to the Recurrence of Postoperative Pulmonary Hypertension in Patients With Congenital Heart Disease

  2021cites this paper
• Sildenafil for pulmonary hypertension in neonates: An updated systematic review and meta‐analysis

  2021cites this paper
• Effectiveness of oral sildenafil for neonates with persistent pulmonary hypertension of newborn (PPHN): a prospective study in a tertiary care hospital

  2021cites this paper
• Continuous and intermittent administration of intravenous sildenafil in critically ill infants with pulmonary hypertension

  2021cites this paper
• Sildenafil in the Management of Pulmonary Hypertension in Newborn

  2020cites this paper
• Oral drugs used to treat persistent pulmonary hypertension of the newborn

  2020cites this paper
• Safety and effect of sildenafil on treating paediatric pulmonary arterial hypertension: a meta-analysis on the randomised controlled trials

  2020cites this paper
• Role of Sildenafil in the Treatment of Persistent Pulmonary Hypertension of Newborn (PPHN) - Should it Be Withdrawn from Market of Bangladesh due to Threat of being Misuses

  2020cites this paper
• Repurposing of the PDE5 inhibitor sildenafil for treatment of persistent pulmonary hypertension in neonates.

  2020cites this paper
• Cost-Utility of Sildenafil for Persistent Pulmonary Hypertension of the Newborn

  2020cites this paper
• Efficacy of Milrinone Plus Sildenafil in the Treatment of Neonates with Persistent Pulmonary Hypertension in Resource-Limited Settings: Results of a Randomized, Double-Blind Trial

  2020cites this paper
• EMERGING ANTENATAL THERAPIES FOR CONGENITAL DIAPHRAGMATIC HERNIA-INDUCED PULMONARY HYPERTENSION IN PRECLINICAL MODELS

  2020cites this paper
• EFFICACY OF ORAL SILDENAFIL IN NEWBORNS HAVING PERSISTENT PULMONARY HYPERTENSION

  2020influential citation
• Transitioning From Intravenous to Subcutaneous Prostacyclin Therapy in Neonates With Severe Pulmonary Hypertension.

  2020cites this paper
• EFFECTIVENESS OF SILDENAFIL IN NEWBORNS & PULMONARY HYPERTENSION

  2020cites this paper
• Investigating Pre and Post-Natal Therapies in the Altered Cardiovascular System of Fetal Growth Restricted Lambs

  2020cites this paper
• Persistent pulmonary hypertension of the newborn

  2020cites this paper
• Persistent Pulmonary Hypertension of Newborn: Analysis of 494 cases in a Tertiary Care Hospital

  2020cites this paper
• A Review on Drug of Pediatric Pulmonary Arterial Hypertension (PAH), their Chemistry and Pharmaceutical Dosage Forms

  2020cites this paper
• Cardiac Therapeutics in Horses.

  2019cites this paper
• Therapies that enhance pulmonary vascular NO-signaling in the neonate.

  2019cites this paper
• Pharmacokinetic modeling of intravenous sildenafil in newborns with congenital diaphragmatic hernia

  2019cites this paper
• Guidelines for the Treatment of Pulmonary Hypertension (JCS 2017/JPCPHS 2017).

  2019cites this paper
• PERSISTENT PULMONARY HYPERTENSION IN NEWBORN RECENT PROGRESS

  2019cites this paper
• Outcomes of Newborn Infants With Pulmonary Hypertension Treated With Oral Sildenafil

  2019cites this paper
• Effects of Maternal Sildenafil Treatment on Vascular Function in Growth-Restricted Fetal Sheep

  2019cites this paper
• Prophylactic Sildenafil in Preterm Infants at Risk of Bronchopulmonary Dysplasia: A Pilot Randomized, Double-Blinded, Placebo-Controlled Trial

  2019cites this paper
• Design and evaluation of novel inhalable sildenafil citrate spray-dried microparticles for pulmonary arterial hypertension.

  2019cites this paper
• Cardiac Physiology and Pharmacology

  2019cites this paper
• The Effect of Phosphodiesterase Type 5 Inhibitors on the Development of Retinopathy of Prematurity in Imam Khomeini Hospital's, Ahvaz, Iran Preterm Infants: A Randomized Clinical Trial

  2019cites this paper
• Thoracoscopic Management of Bochdalek Hernia – Our Experience

  2019cites this paper
• Inhalational versus intravenous magnesium sulfate in management of pulmonary hypertension in neonates

  2019cites this paper
• High mobility group box 1 protein (HMGB1) as biomarker in hypoxia-induced persistent pulmonary hypertension of the newborn: a clinical and in vivo pilot study

  2019cites this paper
• Application of laser scanning cytometry in vascular smooth muscle remodeling

  2018cites this paper
• Sildenafil Exposure in the Neonatal Intensive Care Unit

  2018cites this paper
• Design and rationale of the Fontan Udenafil Exercise Longitudinal (FUEL) trial

  2018cites this paper
• Antenatal sildenafil administration to prevent pulmonary hypertension in congenital diaphragmatic hernia (SToP-PH): study protocol for a phase I/IIb placenta transfer and safety study

  2018cites this paper
• Evaluation of Sildenafil and Tadalafil for Reversing Constriction of Fetal Arteries in a Human Placenta Perfusion Model

  2018cites this paper
• Sildenafil Use in the Treatment of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Case Series

  2018cites this paper
• Phosphodiesterase inhibitors: Potential role in the respiratory distress of neonates

  2018cites this paper
• Antenatal Medical Therapies to Improve Lung Development in Congenital Diaphragmatic Hernia

  2018cites this paper
• Recomendaciones del VIII Consenso Clínico de SIBEN para la Displasia Broncopulmonar

  2018cites this paper
• Bronchopulmonary Dysplasia: An Update of Current Pharmacologic Therapies and New Approaches

  2018cites this paper
• Retrospective review of neonates with persistent pulmonary hypertension of the newborn at Charlotte Maxeke Johannesburg Academic Hospital

  2018cites this paper
• Comparison Of The Efficacy Of Sildenafil Alone Versus Sildenafil Plus Bosentan In Newborns With Persistent Pulmonary Hypertension.

  2018cites this paper
• A Retrospective Review of Infants Receiving Sildenafil.

  2018cites this paper
• Relation Between Inflammatory Indices and The Outcome of Meconium Aspiration Syndrome

  2018cites this paper
• Pointers in Practical Pharmacology: Treatment of Persistent Pulmonary Hypertension of the Newborn: Use of Pulmonary Vasodilators in Term Neonates

  2017cites this paper
• Effect of bosentan therapy in persistent pulmonary hypertension of the newborn.

  2017cites this paper
• A Review of Oxygen Physiology and Appropriate Management of Oxygen Levels in Premature Neonates

  2017cites this paper
• Pulmonary Hypertension Therapy and a Systematic Review of Efficacy and Safety of PDE-5 Inhibitors

  2017cites this paper